Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

corteva agriscience australia pty ltd - halauxifen-methyl; florasulam - water dispersible granule - halauxifen-methyl active 200.0 g/kg; florasulam triazolopyrimidine active 200.0 g/kg - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - propiconazole; liquid hydrocarbon - emulsifiable concentrate - propiconazole triazole active 250.0 g/l; liquid hydrocarbon solvent other 600.0 g/l - fungicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - propiconazole; liquid hydrocarbon (paraffin) - emulsifiable concentrate - propiconazole triazole active 750.0 g/l; liquid hydrocarbon (paraffin) solvent other 242.0 g/l - fungicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

axichem pty ltd - propiconazole; liquid hydrocarbon - emulsifiable concentrate - propiconazole triazole active 250.0 g/l; liquid hydrocarbon solvent other 652.0 g/l - fungicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - terbutryn - suspension concentrate - terbutryn triazine active 500.0 g/l - herbicide

Australia - English - Department of Health (Therapeutic Goods Administration)

olympus australia pty ltd - 45716 - suture knot pusher, reusable - a knot pusher is designed to assist the user performing an internal suturing procedure to advance suture knots creating appropriate suture tension.

Australia - English - Department of Health (Therapeutic Goods Administration)

karl storz endoscopy australia pty ltd - 45716 - suture knot pusher, reusable - a hand-held manual surgical instrument that enables the user performing an internal suturing procedure to advance suture knots created extracorporeally to the point of appropriate suture tension. a long, thin, rod-like device that has a guiding mechanism (e.g., an eyelet or groove) at its distal end, allowing it to be steered down one end of the suture as it pushes the knot with its blunted nose. saline may be used to lubricate the suture and the knot pusher if necessary. this is a reusable device

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - follitropin alfa, quantity: 300 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - follitropin alfa, quantity: 225 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Australia - English - Department of Health (Therapeutic Goods Administration)

gedeon richter australia pty ltd - follitropin alfa, quantity: 450 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- bemfola is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- bemfola in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- bemfola is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.